Prasterone/Estradiol/Drospirenone
普拉睾酮/雌二醇/屈螺酮
Report date: 2024/02/20 16:09:58
Base Information
Drug NamePrasterone/Estradiol/Drospirenone
Drug Alias Name
Classification
Mechanisms of Action +[5]
Targets +[4]
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes DrospirenoneEstradiolPrasterone
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAni Pharmaceuticals Inc
China Registration ClassN/A
Develop Information
Active CompaniesAni Pharmaceuticals IncPantarhei Bioscience Bv
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A